Skip to Content

MYLAN I 400 (Imatinib Mesylate 400 mg)

Pill with imprint MYLAN I 400 is Orange, Elliptical / Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Mylan Pharmaceuticals Inc..

Imatinib is used in the treatment of chronic myelogenous leukemia; dermatofibrosarcoma protuberans; acute lymphoblastic leukemia; chronic eosinophilic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN I 400

Imatinib mesylate 400 mg MYLAN I 400

Imatinib Mesylate

Imprint
MYLAN I 400
Strength
400 mg
Color
Orange
Size
19.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Bcr-abl tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-2246
Inactive Ingredients
silicon dioxide, magnesium stearate, microcrystalline cellulose, ferric oxide red, magnesium silicate, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "MYLAN I 400"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.